Impact of Pretransplantation ¹⁸F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma

Keyphrases

• Non-Hodgkin Lymphoma 100%
• Pretransplant 100%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 100%
• Positron Emission Tomography 100%
• Hematopoietic Cell Transplantation 33%
• Risk Ratio 33%
• Confidence Interval 25%
• Mortality Risk 16%
• Relapse Risk 16%
• Non-associated 8%
• Multivariate Analysis 8%
• Overall Survival 8%
• Increased Mortality 8%
• Chemotherapy 8%
• Failure Risk 8%
• T-cell Lymphoma 8%
• Progression-free Survival 8%
• Transplant Center 8%
• Lymphoma 8%
• Marrow Transplantation 8%
• Graft-versus-host Disease (GvHD) 8%
• Allograft 8%
• Reduced-intensity Conditioning 8%
• Unrelated Donor 8%
• Large Cell 8%
• Follicular Lymphoma 8%
• Non-relapse Mortality 8%
• Risk of Progression 8%

Medicine and Dentistry

• Non-Hodgkin Lymphoma 100%
• Fluorine-18 100%
• Cell Transplantation 100%
• Positron Emission Tomography 100%
• Multivariate Analysis 8%
• Overall Survival 8%
• Progression Free Survival 8%
• Allograft 8%
• Natural Killer Cell 8%
• Reduced Intensity Conditioning 8%
• Graft Versus Host Reaction 8%
• Large Cell 8%
• T-Cell Lymphoma 8%
• Follicular Lymphoma 8%

Immunology and Microbiology

• Hematopoietic Cell 100%
• Cell Transplantation 100%
• Positron Emission Tomography 100%
• T Cell 8%
• Natural Killer Cell 8%
• Conditioning 8%
• Overall Survival 8%
• Graft-Versus-Host Disease 8%
• Progression Free Survival 8%
• Allograft 8%